Nav: Home

Blood vessels sprout under pressure

February 29, 2016

It is blood pressure that drives the opening of small capillaries during angiogenesis. A team of researchers led by Prof. Holger Gerhardt of the MDC observed the process for the first time and published their findings in Nature Cell Biology. The scientists showed how the pressure exerted by the blood causes the membrane of endothelial cells to cave in and grow into the cell's body, until a continuous vessel forms. The cell itself directs the process with the help of the actomyosin filaments of its cytoskeleton. Until now, scientists did not have such a detailed view of how blood capillaries form, which is important in the contexts of embryonic development, cancer or diabetes.

Prof. Gerhardt's teams at the Max Delbrück Center for Molecular Medicine (MDC) in Berlin, the Berlin Institute of Health (BIH), and the German Center for Cardiovascular Research (DZHK) and the Vlaams Instituut voor Biotechnologie (VIB) in Leuven are studying the many different aspects of angiogenesis - the formation of new blood vessels from existing ones.

During "sprouting angiogenesis", new cells grow from the wall of existing nearby capillaries to make a new capillary loop. But until now, scientists did not know how the lumen forms, says Gerhardt.

Using a spinning-disk confocal microscope that provides high spatial and temporal resolution, the researchers studied zebrafish embryos in which the endothelial cell membranes had been genetically labeled with a fluorescing protein. They observed how the blood squeezes into the endothelial cell and, as it does so, the membrane of the new lumen grows. The cell actively controls the progression of the invagination. It pushes back smaller side branches and small bubbles by building actin fibers and then contracting them with the help of myosin filaments. This way the new capillary lumen only grows at the tip.

Capillaries grow whenever blood is required for new areas of tissue - during embryonic development or wound healing, for example. Angiogenesis is also of major importance in cancer. Growing tumors attempt to satisfy their ravenous hunger for energy and oxygen and let blood vessels sprout. "Blood vessels in tumors are not normal. They are leaky and often unable to control their diameter," says Gebala. The property of the lumen may also be relevant to other diseases, says Gerhardt: "If blood vessel formation depends so heavily on the hydrodynamics of the blood, what does this mean for physiological blood pressure?" For example, retinal blood vessels are destroyed in the eyes of diabetics, especially at sites affected by strong fluctuation in blood pressure.

Now the researchers are keen to find out how important the newly discovered mechanism of blood vessel is: "The next logical step is to study pathological situations," says Gebala.
-end-
Holger Gerhardt is research group leader at the MDC holds a "BIH-Professur" for Experimental Cardiovascular Research at the Charité - Universitätsmedizin Berlin, and a "DZHK-Professur".

A longer version of the article can be found at: https://insights.mdc-berlin.de/en/2016/02/blood-vessels-sprout-under-pressure/

Véronique Gebala1,3, Russell Collins1,3, Ilse Geudens2, Li-Kun Phng2,4, Holger Gerhardt1,2,3,5,6 (2016): „Blood flow drives lumen formation by inverse membrane blebbing during angiogenesis in vivo." Nature Cell Biology. doi:10.1038/ncb3320

1 Vascular Biology Laboratory, Cancer Research UK London Research Institute, London, UK; 2 Vascular Patterning Laboratory, Vesalius Research Center, VIB, Department of Oncology, KU Leuven, Belgium; 3 Present address: Integrative Vascular Biology Laboratory, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany; 4 Present address: Department of Cell Biology, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan; 5 DZHK (German Center for Cardiovascular Research), partner site Berlin 6, Berlin Institute of Health (BIH), Berlin, Germany Li-Kun Phng and Holger Gerhardt erqually contributed to the work.

Max Delbrück Center for Molecular Medicine in the Helmholtz Association

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...